serplulimab
fosun pharmaceuticals
['lung', 'serplulimab']
an international randomized phase 3 study presented by dr. ying cheng: serplulimab, a novel anti-pd-1 antibody, plus #chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small-cell lung cancer #asco22 #lungcancer #oncoalert #shanghaihenliusbiotech
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements